Erythema Nodosum
Recent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q1 2027.
Clinical MilestonesViewHide
- 2025-09-01Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum (MaPS in ENLPrimary completion
- 2026-05-26ClinicalA 12-week, Open-label, Randomized, Standard of Care Controlled, Dose-ranging Safety and Efficacy Study of Dovramilast in People With Moderate to Severe Acute or Recurrent Leprosy Type 2 ReactionResults expected Q1 2027
- 2025-09-01ClinicalMethotrexate and Prednisolone Study in Erythema Nodosum Leprosum (MaPS in ENLPrimary completion
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes2
- Erythema Nodosum1
- Granulomatous Mastitis1
Leading journals1
- Frontiers in immunology1
Leading researchers7
- He X1
- Liu J1
- Luo J1
- Wan H1
- Wang X1
- Yang J1
- Zhang H1
Affiliations (unnormalised)5
- Breast Center1
- Clinical Research Center for Breast1
- Laboratory of Tumor Targeted and Immune Therapy1
- Sichuan Provincial Maternity and Child Health Care Hospital1
- West China School of Medicine/West China Hospital1
Reference
Authoritative identity, definition & identifiers.
An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.